Navigation Links
Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil

INDIANAPOLIS and SAO PAULO, Brazil, Jan. 28 /PRNewswire-FirstCall/ -- The Brazilian Ministry of Agriculture has authorized Dow AgroSciences to sell its first corn hybrids with HERCULEX(R) I Insect Protection technology. This authorization was given for 2B710HX, 2B688HX, 2B707HX, 2C520HX and 2A525HX corn hybrids. Dow AgroSciences also announced that it plans to be able to offer the Brazilian market its full range of corn hybrids with this technology in the future.

"This is a key milestone that will make available the best corn seed technology to the Brazilian producer and will set a new standard for insect protection in Brazil," said Jerome Peribere, president and CEO, Dow AgroSciences.

HERCULEX I, approved in Brazil in December 2008 by the National Technical Commission of Biosafety (CTNBio), has been in use in the United States, Argentina and other countries for a number of years. The technology provides effective control of important corn pests by incorporating into the plant the cry1F gene, originated from the Bacillus thuringiensis (Bt) microorganism that naturally occurs in the soil.

HERCULEX I protects the corn plant against the Spodoptora frugiperda caterpillar, the main corn pest in Brazil. This protection is extended to the entire life cycle of the plant. It also allows the control of Diatraea saccharalis. Depending upon growing conditions, these pests may cause yield losses of more 40 percent.

With this technology, Brazilian growers should benefit with higher yield, better quality grain, and a new and effective tool to use as part of an integrated pest management system.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $3.8 billion. Learn more at

(R)HERCULEX is a trademark of Dow AgroSciences LLC

HERCULEX Insect Protection technology developed by Dow AgroSciences and Pioneer Hi-Bred International

SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Dow AgroSciences Success Presented to Wall Street
3. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
4. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
6. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. IsoTis Receives FDA Clearance for Accell Family of Products
Post Your Comments:
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
Breaking Biology Technology:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/2/2016)... , June 2, 2016 The ... has awarded the 44 million US Dollar project, for ... Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... leader in the production and implementation of Identity Management Solutions. ... January, however Decatur was selected for ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):